Researchers at Vanderbilt University Medical Center have isolated the first human monoclonal antibodies (mAbs) that can neutralize norovirus, a virus that causes acute gastrointestinal (GI) illness.
The study, published in the journal Gastroenterology on Aug. 28, 2018, suggests that these isolated mAbs “have high potential” for improving diagnosis and treatment of norovirus illness as well as furthering efforts to develop the first effective norovirus vaccine, according to the research team.
Read more at Scientists Isolate mAbs That Neutralize GI Virus